Free Newsletter
Point BioMedical folds after investor pulls out
Free newsletter via e-mail
Tools
BioSpace takes a look today at the case of Point BioMedical, which is folding its tent after losing the backing of its lead investor. The biotech pulled its NDA for a molecular imaging product as is liquidating its assets. Ex-CEO Tom Feldman says that Vendanta Capital decided not to go ahead with the second tranche of a $50 million financing. The first tranche of $25 million came through in February.
"I can't tell you why they chose not to invest," Feldman told the site.
- read the report from BioSpace
More stories about Point Biomedical
Comments
By Anonymous | Posted 2:38pm | August 26, 2008
Amazing an investor would pull out just like that without a reason if the company was doing well. Feldman can't tell because he is not able to or not willing to tell?
Click here to get the FierceBiotech email newsletter for FREE!
Comments (1) | Post a comment